Workflow
百龙创园: 山东百龙创园生物科技股份有限公司董事和高级管理人员所持本公司股份及其变动管理制度

Core Points - The document outlines the management system for the shares held by directors and senior management of Shandong Bailong Chuangyuan Biotechnology Co., Ltd, emphasizing compliance with relevant laws and regulations [1][2][3] Group 1: General Provisions - The system aims to strengthen the management of shares held by directors and senior management, clarifying procedures based on the Company Law and Securities Law [1] - The system applies to shares held by directors, senior management, and their concerted actors [1] Group 2: Shareholding Change Rules and Information Disclosure - Directors and senior management must notify the board secretary in writing before buying or selling company shares, and the board secretary must verify the situation [2][3] - There are restrictions on the transfer of shares held by directors and senior management, including a one-year lock-up period post-listing and a six-month restriction after leaving the company [4][5] Group 3: Transfer Limitations and Conditions - Directors and senior management can only transfer up to 25% of their shares annually, with exceptions for certain circumstances [5][6] - New shares acquired under specific conditions are subject to different transfer rules, including a 25% limit for unrestricted shares in the year of acquisition [6][7] Group 4: Reporting and Disclosure Obligations - Any changes in shareholding must be reported within two trading days, including details of the change [8][9] - A reduction in shares due to divorce must also comply with the reporting rules [8] Group 5: Penalties and Responsibilities - Violations of the share trading rules may result in internal disciplinary actions or legal consequences, including the recovery of profits from short-term trading [11][12] - The board secretary is responsible for reporting violations to the board, stock exchange, and local regulatory authorities [11][12] Group 6: Miscellaneous Provisions - The system will be effective upon approval by the shareholders' meeting and is subject to interpretation and revision by the board [14]